Annual ROE
-197.98%
-71.22%-56.18%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual return on equity is -197.98%, with the most recent change of -71.22% (-56.18%) on December 31, 2023.
- During the last 3 years, XFOR annual ROE has fallen by -136.47% (-221.87%).
- XFOR annual ROE is now -587.40% below its all-time high of 40.62%, reached on December 31, 2016.
Performance
XFOR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-30.60%
-61.89%-197.79%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly return on equity is -30.60%, with the most recent change of -61.89% (-197.79%) on September 30, 2024.
- Over the past year, XFOR quarterly ROE has dropped by -61.89% (-197.79%).
- XFOR quarterly ROE is now -124.56% below its all-time high of 124.60%, reached on September 30, 2017.
Performance
XFOR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
XFOR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.2% | -197.8% |
| 3 y3 years | -221.9% | -197.8% |
| 5 y5 years | -28.5% | +69.7% |
XFOR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.2% | at low | -197.8% | +88.7% |
| 5 y | 5-year | -384.4% | at low | -197.8% | +88.7% |
| alltime | all time | -587.4% | at low | -124.6% | +88.7% |
X4 Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -30.60%(-197.8%) |
| Jun 2024 | - | 31.29%(-111.6%) |
| Mar 2024 | - | -269.76%(+66.4%) |
| Dec 2023 | -197.98%(+56.2%) | -162.15%(-5.8%) |
| Sep 2023 | - | -172.20%(-24.7%) |
| Jun 2023 | - | -228.66%(+27.5%) |
| Mar 2023 | - | -179.39%(+7.1%) |
| Dec 2022 | -126.76%(-7.9%) | -167.56%(-3.1%) |
| Sep 2022 | - | -172.84%(+11.6%) |
| Jun 2022 | - | -154.85%(+27.6%) |
| Mar 2022 | - | -121.37%(+10.0%) |
| Dec 2021 | -137.70%(+123.9%) | -110.31%(+22.6%) |
| Sep 2021 | - | -89.96%(+12.4%) |
| Jun 2021 | - | -80.00%(+13.3%) |
| Mar 2021 | - | -70.64%(+17.2%) |
| Dec 2020 | -61.51% | -60.27%(+22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -49.32%(-2.9%) |
| Jun 2020 | - | -50.77%(-13.4%) |
| Mar 2020 | - | -58.61%(-21.1%) |
| Dec 2019 | -40.87%(-73.5%) | -74.26%(-26.4%) |
| Sep 2019 | - | -100.95%(+27.1%) |
| Jun 2019 | - | -79.44%(-30.9%) |
| Mar 2019 | - | -114.92%(+17.1%) |
| Dec 2018 | -154.10%(+167.0%) | -98.13%(-5.5%) |
| Sep 2018 | - | -103.82%(-10.8%) |
| Jun 2018 | - | -116.43%(+17.8%) |
| Mar 2018 | - | -98.85%(+2.6%) |
| Dec 2017 | -57.71%(-242.1%) | -96.37%(-177.3%) |
| Sep 2017 | - | 124.60%(+329.5%) |
| Jun 2017 | - | 29.01%(+53.2%) |
| Mar 2017 | - | 18.93%(+101.2%) |
| Dec 2016 | 40.62%(+5.5%) | 9.41% |
| Dec 2015 | 38.51% | - |
FAQ
- What is X4 Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual ROE year-on-year change?
- What is X4 Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly ROE year-on-year change?
What is X4 Pharmaceuticals annual return on equity?
The current annual ROE of XFOR is -197.98%
What is the all time high annual ROE for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual return on equity is 40.62%
What is X4 Pharmaceuticals annual ROE year-on-year change?
Over the past year, XFOR annual return on equity has changed by -71.22% (-56.18%)
What is X4 Pharmaceuticals quarterly return on equity?
The current quarterly ROE of XFOR is -30.60%
What is the all time high quarterly ROE for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly return on equity is 124.60%
What is X4 Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, XFOR quarterly return on equity has changed by -61.89% (-197.79%)